Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip

Markets Investing.com By Investing.com 22 Jul 2026 07:21 1 min read

Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip

Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip

Anthem Biosciences Q1 FY27 slides: margins hold at 40% despite revenue dip

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.